Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells.

Izumiya M, Kabashima A, Higuchi H, Igarashi T, Sakai G, Iizuka H, Nakamura S, Adachi M, Hamamoto Y, Funakoshi S, Takaishi H, Hibi T.

Anticancer Res. 2012 Sep;32(9):3847-53.

PMID:
22993328
2.

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW.

Cancer Res. 2010 Dec 15;70(24):10433-44. doi: 10.1158/0008-5472.CAN-10-2638.

3.

Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition.

Quint K, Tonigold M, Di Fazio P, Montalbano R, Lingelbach S, Rückert F, Alinger B, Ocker M, Neureiter D.

Int J Oncol. 2012 Dec;41(6):2093-102. doi: 10.3892/ijo.2012.1648. Epub 2012 Oct 1.

PMID:
23026911
4.

Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.

Du Z, Qin R, Wei C, Wang M, Shi C, Tian R, Peng C.

Dig Dis Sci. 2011 Mar;56(3):741-50. doi: 10.1007/s10620-010-1340-0. Epub 2010 Aug 4.

PMID:
20683663
5.
6.

Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.

Dang H, Ding W, Emerson D, Rountree CB.

BMC Cancer. 2011 Sep 19;11:396. doi: 10.1186/1471-2407-11-396.

7.

Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells.

Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X, Lu J, Fan X, Zhu S, Wang Y, Guo Q, Wang L, Huang Y, Zhu M, Wang Z.

Cancer Lett. 2013 Oct 28;340(1):113-23. doi: 10.1016/j.canlet.2013.07.009. Epub 2013 Jul 17.

PMID:
23872274
8.

Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.

Sun XD, Liu XE, Huang DS.

Oncol Rep. 2013 Jun;29(6):2401-7. doi: 10.3892/or.2013.2385. Epub 2013 Apr 4.

PMID:
23563640
9.

Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.

Chang ZG, Wei JM, Qin CF, Hao K, Tian XD, Xie K, Xie XH, Yang YM.

Dig Dis Sci. 2012 May;57(5):1181-9. doi: 10.1007/s10620-012-2036-4. Epub 2012 Jan 21.

PMID:
22271412
10.

Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells.

Zhang W, Feng M, Zheng G, Chen Y, Wang X, Pen B, Yin J, Yu Y, He Z.

Biochem Biophys Res Commun. 2012 Jan 13;417(2):679-85. doi: 10.1016/j.bbrc.2011.11.142. Epub 2011 Dec 7.

PMID:
22166209
11.

IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation.

Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J.

Mol Cancer. 2012 Nov 23;11:87. doi: 10.1186/1476-4598-11-87.

12.

Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S.

PLoS One. 2011;6(8):e24099. doi: 10.1371/journal.pone.0024099. Epub 2011 Aug 31.

13.

Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.

Lin CH, Shen YA, Hung PH, Yu YB, Chen YJ.

BMC Complement Altern Med. 2012 Oct 30;12:201. doi: 10.1186/1472-6882-12-201.

14.

In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.

Guzmán-Ramírez N, Völler M, Wetterwald A, Germann M, Cross NA, Rentsch CA, Schalken J, Thalmann GN, Cecchini MG.

Prostate. 2009 Nov 1;69(15):1683-93. doi: 10.1002/pros.21018.

PMID:
19644960
15.

Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.

Ungefroren H, Sebens S, Groth S, Gieseler F, Fändrich F.

Int J Oncol. 2011 Mar;38(3):797-805. doi: 10.3892/ijo.2011.897. Epub 2011 Jan 11.

PMID:
21225226
16.

SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells.

Yasui K, Shimamura M, Mitsutake N, Nagayama Y.

Thyroid. 2013 Aug;23(8):989-96. doi: 10.1089/thy.2012.0319. Epub 2013 Jul 20.

PMID:
23432420
17.

Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.

Kuo SZ, Blair KJ, Rahimy E, Kiang A, Abhold E, Fan JB, Wang-Rodriguez J, Altuna X, Ongkeko WM.

BMC Cancer. 2012 Nov 24;12:556. doi: 10.1186/1471-2407-12-556.

18.

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK, Ahmed N.

J Cell Biochem. 2011 Oct;112(10):2850-64. doi: 10.1002/jcb.23199.

PMID:
21618587
19.

Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.

Kim HM, Haraguchi N, Ishii H, Ohkuma M, Okano M, Mimori K, Eguchi H, Yamamoto H, Nagano H, Sekimoto M, Doki Y, Mori M.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S539-48. doi: 10.1245/s10434-011-2040-5. Epub 2011 Aug 31.

PMID:
21879266
20.

Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties.

Gou S, Liu T, Wang C, Yin T, Li K, Yang M, Zhou J.

Pancreas. 2007 May;34(4):429-35.

PMID:
17446842
Items per page

Supplemental Content

Write to the Help Desk